Timothy Klopfer

Timothy Klopfer serves as a key procurement lead within the Defense Health Agency, overseeing the acquisition of mission-critical medical technologies and support services essential to operational readiness across the Department of Defense. His responsibilities encompass the full lifecycle management of contracts for diagnostic systems, pharmaceutical supply chains, and life sciences research infrastructure, ensuring alignment with DHA’s strategic priorities in clinical precision and medical resilience. He routinely handles complex, high-stakes acquisitions under FAR and DFARS guidelines, with a focus on delivering scalable, interoperable healthcare solutions to military treatment facilities worldwide. Klopfer maintains enduring partnerships with industry leaders including Express Scripts, Leidos, OptumServe, Wisconsin Physicians Service Insurance Corp., and Deloitte Consulting, engaging these vendors to deliver integrated health services, data analytics, clinical support, and enterprise-wide logistics. His procurement approach emphasizes performance-based contracting, outcome-driven service level agreements, and long-term strategic sourcing arrangements that prioritize reliability, continuity, and scalability across the global military health system. His contracting portfolio reflects a strict focus on open competition, with 100% of awards issued under no set-aside preferences, indicating a deliberate emphasis on capability over socioeconomic categorization. While small business participation is not formally prioritized through 8(a), HUBZone, or SDVOSB set-asides, his approach ensures fair and open access to all qualified vendors capable of meeting the DHA’s stringent technical and operational requirements. Klopfer’s primary procurement focus lies in NAICS 541715 (Research and Development in the Physical, Engineering, and Life Sciences) and NAICS 621991 (Blood and Organ Banks), reflecting deep expertise in advancing medical innovation and ensuring the secure, efficient distribution of biological materials and advanced diagnostics. He routinely procures laboratory automation systems, biobanking infrastructure, clinical trial support services, and next-generation diagnostic platforms, underscoring his specialization in the convergence of life sciences research and operational military medicine.